| 101991-8 | 3-hydroxypropyl mercapturate/Creatinine (Urine) | CHEM |
| 101992-6 | Quinolinate/Creatinine (Urine) | CHEM |
| 101993-4 | Kynurenate/Creatinine (Urine) | CHEM |
| 101994-2 | Foundation pain index Document (based on lab data) | CHEM |
| 101995-9 | Foundation Pain Index Score | CHEM |
| 101996-7 | Erythrocytes.Plasmodium falciparum infected/Erythrocytes (Blood, microscopy) | MICRO |
| 101997-5 | Clot initiation.kaolin induced (Blood, thromboelastography) | COAG |
| 101998-3 | Clot formation.kaolin induced (Blood, thromboelastography) | COAG |
| 102-4 | Cefoperazone (serum bactericidal titer) | ABXBACT |
| 1020-7 | E Ag on Red Blood Cells from Donor (qualitative) | BLDBK |
| 10200-4 | Physical findings of Heart Narrative | H&P.PX |
| 102000-7 | Maximum clot strength amplitude (Blood, thromboelastography.kaolin induced) | COAG |
| 102001-5 | Clot initiation.kaolin induced (Blood, thromboelastography^after addition of heparinase) | COAG |
| 102002-3 | Clot formation.kaolin induced (Blood, thromboelastography^after addition of heparinase) | COAG |
| 102003-1 | Reduction in kaolin induced clot strength (Blood, thromboelastography ^30 min p max clot amplitude + heparinase) | COAG |
| 102004-9 | Clot angle.kaolin induced (Blood, thromboelastography^after addition of heparinase) | COAG |
| 102005-6 | Chromium IgE Ab (qualitative, radioallergosorbent test (rast)) | ALLERGY |
| 102006-4 | von Willebrand factor.platelet binding activity without ristocetin in Platelet poor plasma (latex agglutination) | COAG |
| 102007-2 | ACTH heterophile Ab interference Narrative | CHEM |
| 102008-0 | ACTH heterophile Ab interference panel - Plasma | PANEL.CHEM |
| 102009-8 | Clinical pathology Laboratory report | DOC.ONTOLOGY |
| 10201-2 | Physical findings of Mouth and Throat and Teeth Narrative | H&P.PX |
| 102010-6 | The Primary Care PTSD Screen for DSM-5 | PANEL.SURVEY.MTLHLTH |
| 102011-4 | Have you experienced a frightening, horrible, or traumatic event (qualitative) | SURVEY.MTLHLTH |
| 102012-2 | Have you had nightmares or thoughts about the event(s) when you did not want to (qualitative) | SURVEY.MTLHLTH |
| 102013-0 | Have you tried not to think about or avoided situations that reminded you of the event(s) (qualitative) | SURVEY.MTLHLTH |
| 102014-8 | Have you been constantly on guard, watchful, or easily startled (qualitative) | SURVEY.MTLHLTH |
| 102015-5 | Have you felt numb or detached from people, activities, or your surroundings (qualitative) | SURVEY.MTLHLTH |
| 102016-3 | Have you felt guilty or unable to stop blaming yourself or others for the event(s) or any problems the event(s) may have caused (qualitative) | SURVEY.MTLHLTH |
| 102017-1 | PC-PTSD-5 score | SURVEY.MTLHLTH |
| 102018-9 | Glucose --1 hour post dose glucagon | CHAL |
| 102019-7 | Glucose --1.5 hours post dose glucagon | CHAL |
| 10202-0 | Physical findings of Nervous system Narrative | H&P.PX |
| 102020-5 | Glucose --2 hours post dose glucagon | CHAL |
| 102021-3 | Glucose --2.5 hours post dose glucagon | CHAL |
| 102022-1 | Glucose --3 hours post dose glucagon | CHAL |
| 102023-9 | Cortisol --30 minutes post dose glucagon | CHAL |
| 102024-7 | Cortisol --60M post dose glucagon | CHAL |
| 102025-4 | Cortisol --1.5 hours post dose glucagon | CHAL |
| 102026-2 | Cortisol --2 hours post dose glucagon | CHAL |
| 102027-0 | Cortisol --2.5 hours post dose glucagon | CHAL |
| 102028-8 | Cortisol --3 hours post dose glucagon | CHAL |
| 102029-6 | Somatotropin --Fasting post dose insulin IV | CHAL |
| 10203-8 | Physical findings of Nose Narrative | H&P.PX |
| 102030-4 | Ki-67 Nuclear Ag and p16INK4a Ag Ag (Body Fluid, qualitative, immune stain) | CELLMARK |
| 102031-2 | Ki-67 Nuclear Ag and p16INK4a Ag Ag in Cervix (qualitative, immune stain) | CELLMARK |
| 102032-0 | Glucose --2 hours post dose insulin IV | CHAL |
| 102033-8 | Personnel Pathology network list | ADMIN |
| 102034-6 | Pathology report microscopic observation in Specimen | PATH |
| 102035-3 | Screening anti-hypertensive and anti-thrombotic drugs (qualitative) | DRUGDOSE |